A streamlined search technology for identification of synergistic drug combinations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A streamlined search technology for identification of synergistic drug combinations

Published:2015-09-29 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Weiss Andrea,Berndsen Robert H.,Ding Xianting,Ho Chih-Ming,Dyson Paul J.,van den Bergh Hubert,Griffioen Arjan W.,Nowak-Sliwinska Patrycja

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep14508.pdf

Reference52 articles.

1. Gonzalez-Angulo, A. M., Hortobagyi, G. N. & Ellis, L. M. Targeted therapies: peaking beneath the surface of recent bevacizumab trials. Nat Rev Clin Oncol 8, 319–320 (2011).

2. Kitano, H. Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 4, 227–235 (2004).

3. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366, 883–892 (2012).

4. Ebos, J. M., Lee, C. R. & Kerbel, R. S. Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin Cancer Res 15, 5020–5025 (2009).

5. van Beijnum, J. R., Nowak-Sliwinska, P., Huijbers, E. J., Thijssen, V. L. & Griffioen, A. W. The great escape; the hallmarks of resistance to anti-angiogenic therapy. Pharmacol Rev 67, 441–461 (2015).

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of artificial intelligence as a modern technology in advanced cancer therapy;Journal of Drug Delivery Science and Technology;2024-09

2. Optimization of Epigenetic Modifier Drug Combination for Synergistic Effect against Glioblastoma Multiform Cancer Cell Lines;Cancer Investigation;2024-04-20

3. High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line;BMC Cancer;2024-03-12

4. Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections;Pharmaceuticals;2023-12-15

5. HDACIs and TKIs combinations and their liposomal delivery for cancer treatment;Journal of Controlled Release;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3